Author

Karel Allegaert

hoogleraar geneeskunde, KU Leuven - Cited by 17,935 - geneeskunde - klinische farmacologie - kindergeneeskunde - neonatologie

Biography

Karel Allegaert graduated from the University Leuven, Belgium in 2000 as paediatrician-neonatologist. After an additional training at Sophia Children’s Hospital in Rotterdam, he was appointed as clinical consultant neonatology at the University Hospitals Leuven. After his PhD thesis on neonatal analgesia.His current clinical research is supported by a grant of the national research council (Fund for Scientific Research, Flanders (Belgium) by a Fundamental Clinical Investigatorship (1800209 N, 2008-2012). This clinical research resulted in about 140 papers published in international peer reviewed journals
Title
Cited by
Year
Current knowledge, challenges and innovations in developmental pharmacology: A combined conect4children Expert Group and European Society for Developmental, Perinatal and …
A Smits, P Annaert, G Cavallaro, PAJG De Cock, SN de Wildt, ...British journal of clinical pharmacology 88 (12), 4965-4984, 2022202
17
2022
Efficacy and safety of switching from intravenous to oral antibiotics (amoxicillin–clavulanic acid) versus a full course of intravenous antibiotics in neonates with probable …
FM Keij, RF Kornelisse, NG Hartwig, J Van der Sluijs-Bens, ...The Lancet Child & Adolescent Health 6 (11), 799-809, 2022202
5
2022
Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review
D van de Vusse, P Mian, S Schoenmakers, RB Flint, W Visser, K Allegaert, ...European Journal of Clinical Pharmacology 78 (11), 1763-1776, 2022202
4
2022
Development of Best Evidence Dosing Recommendations for Term and Preterm Neonates (NeoDose Project)
MA de Hoop-Sommen, TM van der Zanden, K Allegaert, RB Flint, ...Neonatology 10 (), 196-07, 030
2
2023
Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children
K Cheng, F Mahler, I Lutsar, B Nafria Escalera, S Breitenstein, G Vassal, ...Clinical and Translational Science 16 (3), 478-488, 030
2
2023
Pharmacokinetics of Antimicrobials in Children with Emphasis on Challenges Faced by Low and Middle Income Countries, a Clinical Review
K Meesters, T Alemayehu, S Benou, D Buonsenso, EH Decloedt, ...Antibiotics 1 (1), 17, 0
2
2022
Development of a neonatal Göttingen Minipig model for dose precision in perinatal asphyxia: technical opportunities, challenges, and potential further steps
MS Stroe, L Van Bockstal, A Valenzuela, M Ayuso, K Leys, P Annaert, ...Frontiers in Pediatrics , 6300, 2023202
1
2023
Development and validation of a machine learning-based detection system to improve precision screening for medication errors in the neonatal intensive care unit
N Yalçın, M Kaşıkcı, HT Çelik, K Allegaert, K Demirkan, Ş Yiğit, ...Frontiers in pharmacology 4, 5560, 2023202
1
2023
Low agreement between various eGFR formulae in pediatric and young adult ADPKD patients
P Schellekens, M Verjans, P Janssens, A Dachy, S De Rechter, ...Pediatric Nephrology, -, 2023202
1
2023
Consortium for the Study of Pregnancy Treatments (Co-OPT): An international birth cohort to study the effects of antenatal corticosteroids
EM Frier, C Lin, RM Reynolds, K Allegaert, JV Been, A Fraser, M Gissler, ...PloS one 8 (3), e0282477, 2023202
1
2023
Maternal drugs and breastfeeding: Risk assessment from pharmacokinetics to safety evidence-A contribution from the ConcePTION project
E Cardoso, A Monfort, E Ferreira, H Nordeng, U Winterfeld, K Allegaert, ...Therapies 78 (2), 49-56, 2023202
1
2023
Current pain management practices for preterm infants with necrotizing enterocolitis: a European survey
JA Ten Barge, GE van den Bosch, NJ Meesters, K Allegaert, C Arribas, ...Pediatric Research, -9, 2023202
1
2023
Semi-mechanistic Modeling of Hypoxanthine, Xanthine, and Uric Acid Metabolism in Asphyxiated Neonates
WY Chu, K Allegaert, TPC Dorlo, ADR HuitemaClinical Pharmacokinetics 6 (), 545-558, 2022202
1
2022